Clinical Trials Browser

Interventional × Atorvastatin × Lymphoid × Clear all

COVID-19, Lymphoma, Follicular, Neurologic Manifestations

NCT01988571 2022-01-04

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Phase 2 Completed

279 enrolled 26 charts

BreastLymphoid

Breast Neoplasms, Lymphoma

NCT03066466 2021-04-27

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Phase 3 Withdrawn

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01527045 2020-01-02

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Phase 2 Completed

47 enrolled 18 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT01491958 2018-01-23

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Phase 2 Completed

40 enrolled 10 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00185731 2017-12-02

Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma

Phase 2 Completed

25 enrolled 11 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

NCT01733953 2016-12-14

Statin Therapy in Young Adult Survivors of Childhood Cancer

Phase 2 Completed

27 enrolled 11 charts

LymphoidOther hematologic neoplasm

Cardiovascular Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

STRONGER

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma

Statin Therapy in Young Adult Survivors of Childhood Cancer